Angle

ANGLE


Back



ANGLE is a liquid biopsy company. Our Parsortix® technology enables the capture and harvest of circulating tumor cells (CTCs) from patient blood.
The Parsortix system captures CTCs based on their size, and without antibodies – so capturing the full range of cancer cells, including mesenchymal cells and CTC clusters. The enriched CTC fraction can be analysed by a range of downstream techniques. The CTCs are alive and can be cultured.
Furthermore, ANGLE has in-house capability for multiplex gene expression analysis of enriched CTCs using its HyCEAD® technology. Working with panels of up to 100 genes, the technology provides highly sensitive and robust expression data.
ANGLE has two clinical service labs (US and UK). The labs employ standardized workflows for analysis of epithelial and mesenchymal CTCs and have the capability to develop custom CTC assays. The team is highly experienced in supporting both clinical trials work as well as research studies.





Back